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Objectives. The purpose of this study was to evaluate the 
importance of late infarct-related artery patency for recovery of 
left ventricular function and late survival after primary angio- 
plasty for acute myocardial infarction. 
Background. Infarct-related artery patency is thought o im- 
prove late survival by its effect on preservation of left ventricular 
function. Patency may also enhance late survival by preventing 
left ventricular dilation and reducing arrhythmias, independent of
myocardial salvage. However, most studies have not shown pa- 
tency to be an independent predictor of survival when late left 
ventricular function is taken into account. 
Methods. We followed up 576 hospital survivors of acute 
myocardial infarction treated with primary angioplasty for 5.3 
years. Ejection fraction and infarct-related artery patency were 
determined at follow-up catheterization at 6 months. Predictors of 
late cardiac survival were determined using Cox regression mod- 
els. 
Results. Patients with patent arteries had more improvement 
and a better late ejection fraction than patients with occluded 
arteries (56.3% vs. 47.9%, p = 0.001). In patients with acute 
ejection fraction <45%, late survival was better in those with 
patent versus occluded arteries (89% vs. 44%, p = 0.003), but 
patency was not a significant predictor after improvement in 
ejection fraction was taken into account. In patients with a large 
anterior infarction, patency was a significant independent predic- 
tor of late survival. 
Conclusions. Infarct-related artery patency is important for 
recovery of left ventricular function, and in patients with acute 
ejection fraction <45%, patency is important for late survival. 
Our data are consistent with the hypothesis that the survival 
benefit is due primarily to the effect of patency on recovery of left 
ventricular function. In patients with a large anterior infarction, 
patency appears to provide an additional ate survival benefit 
independent of myocardial salvage. These observations support 
the need for additional clinical trials of late reperfusion in 
patients with a large anterior infarction. 
(J Am Coil Cardiol 1996;28:319-25) 
Myocardial reperfusion has been shown to improve both short- 
and long-term survival in acute myocardial infarction (1,2). 
Although this has been thought o be related primarily to the 
effects of reperfusion on preservation of left ventricular func- 
tion, several observations suggest that reestablishing patency of 
the infarct-related artery may have benefits independent of 
myocardial salvage (2-5). Possible mechanisms for this benefit 
include prevention of left ventricular dilation (6,7), improve- 
ment in electrical stability (8,9) and providing a conduit for 
collateral flow in the event of occlusion of a contralateral 
coronary artery (4,5). 
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Several studies of thrombolytic therapy have shown that 
infarct-related artery patency is a univariate predictor of late 
cardiac survival, but most studies have either not measured late 
left venlricular function or have not shown infarct-related 
artery patency to be an independent predictor of late survival 
when late left ventricular function was taken into account 
(3,10,11). 
The purpose of the present study was to evaluate the 
importance of infarct-related artery patency for late cardiac 
survival after direct angioplasty for acute myocardial infarction 
and to determine whether patency improves late survival 
through its effect on recovery of left ventricular function or 
whether there is a beneficial effect that is independent of 
myocardial salvage. 
Methods  
Study subjects. From 1984 through 1991, 633 consecutive 
patients with an acute myocardial infarction and a diagnostic 
electrocardiogram (ECG) who were treated with primary 
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angioplasty without prior thrombolytic therapy were prospec- 
tively entered into an ongoing data base. Diagnostic ECGs 
were defined as ST segment elevation ->1 mm in two or more 
contiguous leads, reciprocal ST segment depression ->1 mm in 
leads V 1 to V2 or left bundle branch block. Patients were not 
treated with primary angioplasty if they had severe comorbid 
disease or presented >12 h after the onset of infarction. 
Primary angioplasty is the preferred reperfusion strategy at our 
institution, where -77% of patients with a diagnostic ECG 
have undergone acute catheterization, and 70% have been 
treated with primary angioplasty (12). Of the 633 patients 
treated with primary angioplasty, there were 576 hospital 
survivors who comprise our study population. 
Treatment protocol. Patients presenting to the emergency 
department were given 10,000 U of heparin and chewable 
aspirin and transported promptly to the cardiac atheterization 
laboratory. Cardiac catheterization was performed, and coro- 
nary reperfusion was established mechanically with primary 
angioplasty as previously described (13). Patients were treated 
with intravenous heparin for 3 to 5 days to prolong the partial 
thromboplastin time to 60 to 80 s. Aspirin was given routinely, 
and beta-adrenergic blocking drugs and nitrates were given at 
the discretion of the attending physician. Reinfarction and 
recurrent ischemia were treated when appropriate with repeat 
angioplasty or coronary bypass surgery in an attempt to 
maintain patency of the infarct-related artery. 
Follow.up catheterization and angiography. Follow-up 
catheterization a d angiography were performed routinely for 
the first 3 years of the study and for an 18-month period from 
1990 to 1991 during follow-up of the Primary Angioplasty 
Registry (14). Otherwise, follow-up catheterization was per- 
formed for recurrent ischemic symptoms or abnormal func- 
tional testing. Follow-up catheterization was performed in 374 
(65%) of 576 patients at a median follow-up time of 5.6 
months. In 316 of these studies (55% of all patients), left 
ventricular cineangiograms were adequate for calculation of 
follow-up ejection fraction. Left ventricular ejection fractions 
were calculated from tracing contours of right anterior oblique 
cineangiograms u ing the area-length method with correction 
for the right anterior oblique projection (15). In 10 patients 
who died after hospital discharge without follow-up angiogra- 
phy, follow-up left ventricular ejection fraction measured by 
radionuclide ventriculography was used in the analysis. 
Clinical follow-up. Clinical follow-up was obtained by hos- 
pital and office chart review and telephone contact. Events 
recorded included death, cause of death, reinfarction, repeat 
angioplasty and bypass urgery. Complete follow-up was ob- 
tained in 565 (98%) of 576 patients at a median follow-up time 
of 5.3 years. 
Data analysis. Variables examined as predictors of late 
cardiac survival included age, gender, prior myocardial infarc- 
tion, prior coronary bypass urgery, cardiogenic shock before 
intervention, infarct location, multivessel coronary artery dis- 
ease, acute left ventricular ejection fraction, late (follow-up) 
ejection fraction, improvement in ejection fraction and infarct- 
related artery patency. 
Infarct-related artery patency was determined at follow-up 
catheterization in 374 (65%) of 576 patients. The infarct artery 
was considered patent at follow-up angiography if the flow was 
Thrombolysis in Myocardial Infarction (TIMI) grade 2 or 3 
(339 patients). In patients who did not have follow-up cathe- 
terization, the infarct artery was considered patent if the initial 
primary angioplasty procedure was successful and there was no 
reinfarction (182 patients) or, in the case of patients with 
unsuccessful angioplasty, if the patient underwent coronary 
artery bypass surgery during the initial hospital period (7 
patients). The infarct artery was considered occluded at 
follow-up angiography if the flow was TIMI grade 0 or 1 (35 
patients). In patients who did not have follow up angiography, 
the infarct artery was considered occluded if the angioplasty 
procedure was unsuccessful (10 patients) or if there was 
reinfarction without repeat revascularization (3 patients). 
Comparisons of baseline variables between subgroups were 
performed using the chi-square statistic and Student two-tailed 
t tests. Differences in late cardiac survival across categories of 
discrete predictor variables were examined with Kaplan-Meier 
survival curves and their associated log-rank test statistics. 
Multivariable analyses of predictors of late cardiac survival 
were performed using Cox proportional hazards regression 
models. A stepwise selection method was used with an inclu- 
sion criteria of a p value <-0.10. Only patients with patency 
documented at follow-up angiography and paired ejection 
fraction data were included in multivariable analyses that 
evaluated improvement in ejection fraction or late ejection 
fraction as potential predictor variables. All analyses were 
performed with SAS and SPSS statistical software. 
Resul ts  
Of 633 patients treated with primary angioplasty, 57 died in 
the hospital, and 576 survived the hospital period. Reperfusion 
with angioplasty was successful in 595 patients (94%). Coro- 
nary artery bypass urgery was performed uring the hospital 
period in 44 patients (7.0%) and repeat angioplasty of the 
infarct-related artery in 25. 
Baseline characteristics. The baseline characteristics of 
the 576 hospital survivors are shown in Tables 1 and 2. Patients 
with follow-up angiography were younger and had a lower 
incidence of cardiogenic shock, a higher incidence of anterior 
infarction and a lower acute mean ejection fraction than 
patients without follow-up angiography (Table 1). Patients 
with a patent infarct-related artery had fewer prior infarctions 
and more multivessel disease than patients with occluded 
arteries (Table 2). 
Late follow-up. The 576 hospital survivors were followed 
up for a median of 5.3 years. There were 37 late noncardiac 
and 48 late cardiac deaths (28 sudden deaths). The late infarct 
artery patency rate in patients with follow-up angiography was 
91%. 
Predictors of late cardiac survival. Kaplan-Meier survival 
curves for selected predictor variables are shown in Figure 1. 
Significant univariate predictors of late survival by the log-rank 
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Table 1. Baseline Characteristics of 576 Patients Discharged From 
Hospital After Primary Angioplasty for Acute Myocardial Infarction 
With and Without Follow-Up Angiography 
Follow-Up No Follow-Up 
Angiography Angiography All Pts 
(n = 374) (n = 202) (n = 576) 
Age (yr) 57 _+ 11' 61 + 11 58 _+ 11 
Women 95 (25) 52 (26) 147 (26) 
Prior MI 63 (17) 46 (23) 109 (19) 
Prior CABG 13 (3.5) 7 (3.5) 20 (3.5) 
Cardiogenic shock 15 (4.0)¢ 18 (8.9) 33 (5.7) 
Ant MI 172 (46)* 70 (35) 242 (42) 
Multivessel CAD 195 (52) 104 (52) 299 (52) 
Reperfusion time (h) 4.1 _+ 3.3 4.3 + 3.3 4.2 ÷ 3.3 
Acute EF (%) 52.2 _+ 13" 55.6 _+ 12 53.4 _+ 13 
*p < 0.01, tP < 0.05 versus patients (Pts) with no follow-up angiography. 
Data presented are mean value + SD or number (%) of patients. Ant = anterior; 
CABG = coronary artery bypass graft surgery; CAD = coronary artery disease; 
EF - ejection fraction; MI = myocardial infarction. 
test were acute ejection fraction (p = 0.002), late ejection 
fraction (p < 0.001), improvement in ejection fraction (p < 
0.001), prior coronary bypass surgery (p < 0.001) and multives- 
sel coronary disease (p = 0.008). Survival curves were not 
significantly different in patients with a patent versus an 
occluded infarct-related artery (p = 0.43). 
Multivariable predictors of late cardiac survival in a Cox 
proportional hazards model are shown in Table 3. When acute 
ejection fraction was included in the model (model 1), signif- 
icant predictors of late cardiac survival were acute ejection 
fraction (p = 0.01), prior bypass surgery (p = 0.01) and 
infarct-related artery patency (p = 0.03). When improvement 
in ejection fraction was added to the model (model 2), 
significant predictors were improvement in ejection fraction 
(p < 0.0001), acute ejection fraction (p = 0.0003), prior bypass 
surgery (p = 0.01) and gender (p = 0.03); infarct artery 
patency was no longer a significant predictor. When late 
ejection fraction was included in the model (model 3), signif- 
icant predictors were late ejection fraction (p < 0.0001), prior 
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Figure 1. Kaplan-Meier cardiac survival curves after primary angio- 
plasty for acute myocardial infarction comparing three predictor 
variables: A, acute ejection fraction (EF) ->45%, versus <45%; B, late 
ejection fraction ->45% versus <45%; C, patent versus occluded 
infarct-related arteries at follow-up. 
Table 2. Baseline Characteristics in 576 Patients According to 
Infarct-Related Artery Patency 
Patent IRA Occluded IRA p 
(n = 528) (n = 48) Value 
Age (yr) 58 _+ 11 58 + 12 NS 
Women 132 (25) 15 (31) NS 
Prior MI 95 (18) 14 (29) 0.06 
Prior CABG 18 (3.4) 2 (4.2) NS 
Cardiogenic shock 30 (5.7) 3 (6.3) NS 
Ant MI 224 (42) 18 (38) NS 
Multivessel CAD 282 (53) 17 (35) 0.02 
Reperfusion time (h) 4.2 _+ 3.3 4.2 _+ 3.5 NS 
Acute EF (%) 53.5 _+ 13 52.1 _+ 11 NS 
Data presented are mean value _+ SD or number (%) of patients. IRA = 
infarct-related artery; other abbreviations as in Table 1. 
bypass surgery (p = 0.01) and gender (p = 0.04); patency was 
not a significant predictor. 
Effect of infarct-related artery patency on recovery of left 
ventricular function. Acute and follow-up left ventricular 
ejection fraction in patients with paired data are shown in 
Figure 2 and Table 4. Patients with a patent versus an occluded 
infarct-related artery had more improvement in ejection frac- 
tion (4.9% vs. -3.4%, p < 0.0001) and a higher follow-up 
ejection fraction (56.3% vs. 47.9%, p = 0.001). These differ- 
ences were also true within each subgroup evaluated (Table 4). 
Effect of infarct.related artery patency on late cardiac 
survival in subgroups. The correlation between infarct- 
related artery patency and late cardiac survival in the sub- 
groups is shown in Figure 3 and Table 5, and the results of the 
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Figure 2. Acute and follow-up ejection fraction (mean _+ SD) after 
primary angioplasty for acute myocardial infarction in patients with a 
patent versus occluded infarct-related artery (paired ejection fraction 
data). Patients with a patent artery had a significantly higher follow-up 
ejection fraction than did patients with occluded arteries. Open bars = 
patent infarct-related artery (n = 271); gray bars = occluded infarct- 
related artery (n = 31)• 
multivariable analyses are shown in Table 3. In patients with an 
acute ejection fraction ->45%, patency was not a significant 
univariate predictor of late cardiac survival (Fig. 3, Table 5). In 
patients with an acute ejection fraction <45%, patency was a 
strong univariate predictor of late survival (Fig. 3, Table 5) and 
was the strongest predictor of late cardiac survival in a 
multivariable model that included acute left ventricular ejec- 
tion fraction (before recovery of left ventricular function) 
(model 4, Table 3). When late ejection fraction (reflecting 
recovery of left ventricular function) was added to the model, 
patency did not reach significance as an independent predictor 
(model 6, Table 3). 
In patients with an anterior infarction, patency was a strong 
univariate predictor of late survival (Fig. 3, Table 5) and was 
the strongest predictor of late cardiac survival in a multivari- 
able model that included acute ejection fraction. When im- 
provement in ejection fraction or late ejection fraction (reflect- 
ing recovery of left ventricular function) was included in the 
model, patency was no longer a significant predictor of late 
survival. 
In patients with an anterior infarction and acute ejection 
fraction <45%, patency was a significant independent predic- 
tor of late cardiac survival in multivariable models that in- 
cluded improvement in ejection fraction or late ejection frac- 
tion (models 8 and 9, Table 3). Among the patients with a 
non-anterior-wall infarction and acute ejection fraction -<45%, 
there were only two with occluded arteries, so no meaningful 
statistical comparisons could be made in this subgroup. 
Discuss ion  
Our study confirms that in the reperfusion era, left ventric- 
ular function remains the most important determinant of late 
cardiac survival. Infarct-related artery patency is important for 
recovery of left ventricular function, and in patients with an 
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Table 4. Relation Between Infarct-Related Artery Patency and 
Left Ventricular Ejection Fraction in Patients With Paired 
Ejection Fraction 
Patent IRA Occluded IRA 
(mean _+ SD) (mean _+ SD) p Value 
All pts (n = 302 
[patent 271, occluded 3]) 
Acute EF (%) 51.3 _+ 12 51.3 _+ 10 NS* 
Follow-up EF (%) 56.3 _+ 14 47.9 _+ 12 0.001 
improvement EF (%) 4.9 _+ 11 3.4 _+ 10 0.0001 
Acute EF >45% (n = 204 
[patent 181, occluded 23]) 
Acute EF (%) 58.5 _+ 9 56.6 _+ 7 NS* 
Follow-up EF (%) 61.6 _+ 10 50.7 _+ 9 <0.0001 
Improvement EF (%) 3.1 _+ 10 -5.9 _+ 6 <0.0001 
Acute EF <45% (n = 98 
[patent 90, occluded 8]) 
Acute EF (%) 36.9 + 7 36.3 + 4 NS* 
Follow-up EF (%) 45.5 _+ 15 40.0 _+ 17 NS* 
Improvement EF (%) 8.6 _+ 13 3.8 _+ 16 NS* 
Ant MI (n = 140 [patent 128, 
occluded 12]) 
Acute EF (%) 45.5 _+ 12 45.8 _+ 10 NS* 
Follow-up EF (%) 53.7 _+ 16 43.8 _+ 13 0.03 
Improvement EF (%) 8.2 _+ 12 -2.0 _+ 11 0.008 
Non-Ant MI (n - 162 [patent 
143, occluded 19]) 
Acute EF (%) 56.6 + 12 54.8 +_ 10 NS* 
Follow-up EF (%) 58.6 + 12 50.5 + 11 0.008 
Improvement EF (%) 2.0 + 10 -4.3 _+ 10 0.02 
Ant MI with acute EF <45% 
(n 69 [patent 63, 
occluded 6]) 
Acute EF (%) 36.3 + 7 36.8 * 4 NS* 
Follow-up EF (%) 44.9 + 15 38.3 -* 16 NS* 
Improvement EF (%) 8.7 _+ 13 1.5 - 15 NS* 
*p > 0.10. Abbreviations a in Tables 1 and 2. 
anterior infarction or acute left ventricular dysfunction, pa- 
tency is a strong univariate predictor of late cardiac survival. 
However, patency is not a significant independent predictor of 
late survival in these patients after improvement in left ven- 
tricular function is accounted for. In patients who have both an 
anterior infarction and acute left ventricular dysfunction, in- 
farct artery patency is a significant predictor of late cardiac 
survival independent of its effect on recovery of left ventricular 
function. 
Previous studies regarding importance of infarct-related 
artery pateney for late cardiac survival. The Global Utiliza- 
tion of Streptokinase and t-PA for Occluded Coronary Arter- 
ies (GUSTO) (16) angiographic investigators have convinc- 
ingly shown the importance of infarct-related artery patency 
for hospital survival. Infarct artery patency also appears to be 
important for late (posthospital) cardiac survival (3,10,11,17- 
19), but it has not been clear whether this is related to the 
effect of infarct artery patency on recovery of left ventricular 
function or whether patency has an independent effect on late 
survival. Several studies of thrombolytic therapy have shown 
that infarct artery patency is an important univariate predictor 
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Figure 3. Kaplan-Meier cardiac survival curves after primary angio- 
plasty for acute myocardial infarction comparing patients with a patent 
versus occluded infarct-related artery in three subgroups: A, patients 
with acute ejection fraction >-45%; B, patients with acute ejection 
fraction <45%; and C, patients with an anterior infarction. 
of late cardiac survival (3,10,11,17,19), but most studies either 
have not measured late left ventricular function or have not 
shown infarct artery patency to be an independent predictor of 
late cardiac survival when late left ventricular function was 
included in the multivariable analyses. The Western Washing- 
ton Intracoronary Streptokinase trial (3) showed that infarct 
artery patency was an independent predictor of late cardiac 
survival when acute ejection fraction was included in the 
analyses. However, when left ventricular ejection fraction 
measured at 3 days (after some recovery had occurred) was 
included in the multivariable analyses, infarct artery patency 
was no longer a significant predictor of late cardiac survival 
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Table 5. Relation Between Infarct-Related Artery Patency and Late 
Cardiac Mortality in Patient Subgroups 
Patent Occluded p 
Variable IRA IRA Value 
All pts (n : 565) 40/518 (7.7) 7/47 (15) 0.09 
Acute EF ->45% (n = 367) 23/332 (6.9) 2/35 (5.7) NS* 
Acute EF <45% (n = 132) 14/123 (11) 5/9 (56) 0.0003 
Ant MI (n = 236) 18/219 (8.2) 6/17 (35) 0.0004 
Non-Ant MI (n = 329) 22/299 (7.4) 1/30 (3.3) NS* 
Ant MI with acute EF <45% 6/81 (7.4) 5/7 (71) < 0.0001 
(n : 88) 
*p > 0.10. Data presented are number of deaths/number of patients (%). 
Abbreviations a  in Tables i and 2. 
(20). Likewise, the Interuniversity Cardiology Institute of The 
Netherlands trial (11), in which patients with acute myocardial 
infarction were treated with intracoronary streptokinase or 
urokinase, found that infarct artery pateney was a univariate 
predictor of late survival, but patency was no longer a predictor 
of survival when patients were stratified by ejection fraction. 
Both of these studies suggest hat infarct artery patency 
improves late cardiac survival primarily by its effect on recov- 
ery of left ventricular function. 
Two studies to date have suggested that infarct-related 
artery patency may have a beneficial effect on late cardiac 
survival, independent of myocardial salvage (21,22). White et 
al. (21) measured left ventricular function 4 weeks after 
infarction and found that infarct artery patency (when ex- 
pressed as a variable that included the amount of myocardium 
supplied by the infarct artery) was an independent predictor of 
late cardiac survival. Infarct artery patency was most important 
for late survival in patients with depressed left ventricular 
function. Likewise, the Survival and Ventricular Enlargement 
(SAVE) Investigators (22) assessed infarct artery patency and 
left ventricular ejection fraction 4 days after infarction in 
patients with left ventricular dysfunction (ejection fraction 
<40%) and found patency to be a significant predictor of late 
survival after correcting for differences in left ventricular 
ejection fraction and other predictor variables (22). 
Comparison of our results with those of previous tudies. 
Our data support he findings of previous tudies of primary 
angioplasty (14,23) and thrombolytic therapy (24) that late 
infarct-related artery patency is important for recovery of left 
ventricular function. In patients with a small infarction, late 
survival is very good, and infarct-related artery patency has 
very little effect on late cardiac survival. In patients with an 
anterior infarction or acutely depressed left ventricular func- 
tion, infarct artery patency is a strong univariate predictor of 
late survival but is not a significant independent predictor after 
improvement in left ventricular function has been taken into 
account. This is similar to the findings of Sheehan et al. (20) 
and The Netherlands trial (11). However, in patients with an 
anterior infarction and acute left ventricular dysfunction, pa- 
tency appears to have a beneficial effect on late cardiac survival 
that is independent ofmyocardial salvage. This is similar to the 
findings of White et al. (21) and the SAVE Investigators (22). 
There are several possible mechanisms for the independent 
effects of infarct-related artery patency on late cardiac survival. 
These have been well described elsewhere and include preven- 
tion of left ventricular dilation or remodeling (6,7), improve- 
ment in electrical stability (8,9) and providing a conduit for 
collateral flow in the event of an occlusion of a contralateral 
artery (4,5). 
Study limitations. Our study is limited because follow-up 
angiography was obtained in only 65% of patients. Patients 
with follow-up angiography were younger and had a higher 
incidence of anterior infarction and a lower acute ejection 
fraction than patients without follow-up angiography. Patients 
with an anterior infarction and a low acute ejection fraction 
have greater improvement in ejection fraction after successful 
reperfusion (23), so this could result in an overestimation f
improvement in ejection fraction in our patients. Patients with 
a low acute ejection fraction have higher late mortality, so our 
analyses of patients with follow-up angiography could result in 
an overestimation f late mortality. 
Coronary artery bypass urgery was performed before dis- 
charge in 40 hospital survivors in the patent artery group (vs. 
none in the occluded artery group), making it difficult to 
determine whether patency or bypass urgery is more impor- 
tant for late survival in these patients. However, late mortality 
was higher in patients with (15%) than without bypass urgery 
(7.8%), so it seems unlikely that the use of bypass surgery 
greatly influenced our results. 
Finally, the relatively small number of late cardiac deaths 
and the relatively small number of patients with an occluded 
infarct-related artery limit our subgroup analyses. 
Clinical implications. Our data confirm that late infarct- 
related artery patency is important for recovery of left ventric- 
ular function. In patients with a small myocardial infarction, 
survival is very good, and infarct artery patency has very little 
effect on late survival. In patients with an anterior infarction or 
acute left ventricular dysfunction, patency is important for late 
survival but is not a significant independent predictor after 
correction for recovery of left ventricular function. These data 
are consistent with the hypothesis that in patients with an 
anterior infarction or left ventricular dysfunction, patency 
improves late survival primarily by its effect on recovery of left 
ventricular function. In patients with an anterior infarction and 
acute left ventricular dysfunction, patency appears to provide 
an additional beneficial effect on late cardiac survival that is 
independent ofmyocardial salvage. These observations should 
encourage prospective studies to evaluate the survival benefit 
of late coronary reperfusion (when myocardial salvage is no 
longer expected) in patients with a large anterior infarction. 
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